Norén GN

ORCID: 0000-0002-4595-230X · 2 papers in corpus
2020
Drug safety ·doi:10.1007/s40264-020-00957-w

IntroductionIn the treatment of the individual patient, a vision is to achieve the best possible balance between benefit and harm. Such tailored therapy relies upon the identification and characterisation of risk factors for adverse drug re…

2015
Drug safety ·doi:10.1007/s40264-014-0251-y

BackgroundPharmacovigilance signal detection largely relies on individual case reports, but longitudinal health data are being explored as complementary information sources. Research to date has focused on the ability of epidemiological met…